Literature DB >> 30572139

Nailfold avascular score and coronary microvascular dysfunction in systemic sclerosis: A newsworthy association.

Elisabetta Zanatta1, Giulia Famoso2, Francesca Boscain2, Roberta Montisci3, Erika Pigatto1, Pamela Polito1, Franco Schiavon1, Sabino Iliceto2, Franco Cozzi1, Andrea Doria4, Francesco Tona2.   

Abstract

BACKGROUND AND AIMS: We aimed to assess the relationship between nailfold videocapillaroscopy (NVC) abnormalities and coronary flow reserve (CFR), a marker of coronary microvascular dysfunction (CMD) in patients with systemic sclerosis (SSc).
METHODS: We studied 39 SSc patients (33 females, mean ± SD age 54 ± 12 years, median disease duration 11 years, range 6-22) and 22 controls (matched for age and sex) without any evidence of cardiovascular disease. Clinical assessment was performed by modified Rodnan skin score (mRss) and EUSTAR score. Coronary flow velocities in the left anterior descending coronary artery were measured by transthoracic echocardiography. Average peak flow velocities, CFR and microvascular resistance at baseline (BMR) and in hyperaemic (HMR) condition were assessed. CFR ≤2.5 was considered marker of CMD. Six NVC-abnormalities were evaluated by a semi quantitative scoring system: enlarged and giant capillaries (diameter > 20 μm and >50 μm, respectively), hemorrhages, disarray, capillary ramifications and loss of capillaries (avascular score). Statistic was performed using SPSS.
RESULTS: CFR was lower in SSc patients than in controls (2.6 ± 0.5 vs 3.3 ± 0.5). CMD was detected in 24 patients (61.5%) vs 0 controls (p < .0001). CFR was inversely correlated with NVC-avascular score (rho =-0.750, p < .0001). Avascular and capillary ramifications scores (p = .001 and p = .03, respectively), mRss (p = .003) and EUSTAR score (p = .01) were higher in patients with CMD than in those without. At multivariable analysis, avascular score was independently associated with CMD (p = .01). HMR was directly correlated with avascular score (rho = 0.416, p = .008).
CONCLUSIONS: In our SSc patients NVC-avascular score was associated with CMD which seems to be the result of a structural microvascular remodeling.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Avascular score; Coronary flow reserve; Coronary microvascular dysfunction; Coronary microvascular resistance; Nailfold videocapillaroscopy; Systemic sclerosis

Mesh:

Year:  2018        PMID: 30572139     DOI: 10.1016/j.autrev.2018.09.002

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  5 in total

Review 1.  Endothelial Dysfunction and Coronary Vasoreactivity - A Review of the History, Physiology, Diagnostic Techniques, and Clinical Relevance.

Authors:  Tharusha Gunawardena; Ioannis Merinopoulos; Upul Wickramarachchi; Vassilios Vassiliou; Simon Eccleshall
Journal:  Curr Cardiol Rev       Date:  2021

Review 2.  Inflammation and Coronary Microvascular Dysfunction in Autoimmune Rheumatic Diseases.

Authors:  Elisabetta Zanatta; Claudia Colombo; Gianpiero D'Amico; Thomas d'Humières; Carlo Dal Lin; Francesco Tona
Journal:  Int J Mol Sci       Date:  2019-11-07       Impact factor: 5.923

3.  State-of-the-art technologies provide new insights linking skin and blood vessel abnormalities in SSc-related disorders.

Authors:  Graham Dinsdale; Sarah Wilkinson; Jack Wilkinson; Tonia L Moore; Joanne B Manning; Michael Berks; Elizabeth Marjanovic; Mark Dickinson; Ariane L Herrick; Andrea K Murray
Journal:  Microvasc Res       Date:  2020-04-19       Impact factor: 3.514

4.  Association Between Uric Acid and Worsening Peripheral Microangiopathy in Systemic Sclerosis.

Authors:  Eleni Pagkopoulou; Stergios Soulaidopoulos; Eva Triantafyllidou; Afrodite Malliari; George D Kitas; Alexandros Garyfallos; Theodoros Dimitroulas
Journal:  Front Med (Lausanne)       Date:  2021-12-24

5.  Peripheral microcirculatory abnormalities are associated with cardiovascular risk in systemic sclerosis: a nailfold video capillaroscopy study.

Authors:  Eleni Pagkopoulou; Stergios Soulaidopoulos; Eva Triantafyllidou; Alexandra Arvanitaki; Niki Katsiki; Chalarampos Loutradis; Asterios Karagiannis; Michael Doumas; Alexandros Garyfallos; George D Kitas; Theodoros Dimitroulas
Journal:  Clin Rheumatol       Date:  2021-07-27       Impact factor: 2.980

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.